Page last updated: 2024-10-27

gabexate and Leukemia, Promyelocytic, Acute

gabexate has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomita, N1
Kanamori, H1
Fujita, H1
Maruta, A1
Naitoh, A1
Nakamura, S1
Ota, Y1
Nozue, N1
Kihara, M1
Ishigatsubo, Y1

Other Studies

1 other study available for gabexate and Leukemia, Promyelocytic, Acute

ArticleYear
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
    Anti-cancer drugs, 2001, Volume: 12, Issue:8

    Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic

2001